Literature DB >> 6149958

Behavioral and electrophysiological studies of peptide-induced emesis in dogs.

D O Carpenter, D B Briggs, N Strominger.   

Abstract

The electrophysiological responses of neurons in the canine area postrema (AP) to ionophoretic application of neuropeptides and transmitters were studied and correlated with the presence or absence of an emetic response on systemic administration. Of 17 common neuropeptides 11 were emetic when applied systemically at doses of 0.03-0.35 mg/kg. The emesis was dose dependent and was no longer observed in animals with chronic ablation of the AP. The responses of 122 AP single units were recorded. Neurons were silent at rest, and most were excited by glutamate, apomorphine, and dopamine. Excitatory responses to each of eight emetic peptides were recorded in 22-65% of cells studied; no responses were found to two peptides that were not emetic. The response to glutamate was always a brief, high-frequency discharge; the responses to all 13 other excitatory substances were of long latency, low frequency, and long duration. With high ionophoretic current or multiple applications, units would frequently become spontaneously active for many minutes or longer. The similarity of response of so many substances on small neurons suggests a common ionic or metabolic mechanism underlying the response. The direct correlation between the occurrence of emesis on systemic administration and the presence of excitatory receptors on AP neurons provides strong support for the proposed role of the AP as the chemoreceptor trigger zone for emesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149958

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  12 in total

Review 1.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 2.  Pathophysiology of cytotoxic drug-induced emesis: far from crystal-clear.

Authors:  C Seynaeve; P H De Mulder; J Verweij
Journal:  Pharm Weekbl Sci       Date:  1991-02-22

3.  Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.

Authors:  Nissar A Darmani; Yaozhi Wang; Joseph Abad; Andrew P Ray; Gerald R Thrush; Juan Ramirez
Journal:  Brain Res       Date:  2008-04-09       Impact factor: 3.252

4.  Ablation of least shrew central neurokinin NK1 receptors reduces GR73632-induced vomiting.

Authors:  Andrew P Ray; Seetha Chebolu; Juan Ramirez; Nissar A Darmani
Journal:  Behav Neurosci       Date:  2009-06       Impact factor: 1.912

Review 5.  Do conditioned taste aversions result from activation of emetic mechanisms?

Authors:  V L Grant
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 6.  Chemotherapy induced emesis--mechanisms and treatment: a review.

Authors:  C M Edwards
Journal:  J R Soc Med       Date:  1988-11       Impact factor: 18.000

7.  AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the development of motion sickness in rat.

Authors:  Li-Hua Xu; Guan-Rong Tang; Juan-Juan Yang; Hong-Xia Liu; Jian-Cheng Li; Zheng-Lin Jiang
Journal:  Mol Brain       Date:  2015-12-12       Impact factor: 4.041

Review 8.  Neurokinin-1 Antagonists for Postoperative Nausea and Vomiting.

Authors:  Zhaosheng Jin; Neil Daksla; Tong J Gan
Journal:  Drugs       Date:  2021-06-09       Impact factor: 9.546

Review 9.  Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.

Authors:  Weixia Zhong; Omar Shahbaz; Garrett Teskey; Abrianna Beever; Nala Kachour; Vishwanath Venketaraman; Nissar A Darmani
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

10.  Arginine vasopressin--a mediator of chemotherapy induced emesis?

Authors:  C M Edwards; J Carmichael; P H Baylis; A L Harris
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.